Digital Therapeutics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	150 Pages	Coherent Market Insights	June, 2023	CMI18049170

Best Price Guarantee
Price	from $4,500
Length	150 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049170

Digital Therapeutics Market, By Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), By Product Type (Software and Device), By Sales Channel ((Business-to-Business (B2B) (Employer, Healthcare Provider, and Others) and Business-to-Consumer (B2C) (Patient and Caregiver), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by the software to prevent, manage, or treat a medical disorder or disease. Digital Therapeutics are a part of the digital healthcare that deliver therapeutic interventions directly to patients via evidence-based, clinically-evaluated software for disease management.

Market Dynamics:

Increasing burden of chronic diseases, the outbreak of COVID-19 (pandemic), increasing adoption of patient-centric healthcare apps, growing adoption of digital healthcare solutions or technologies, and increasing focus toward preventive healthcare by governments are major factors expected to augment the growth of the global digital therapeutics market.

For instance, in February 2022, DynamiCare Health Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the DCH-001, a prescription-only digital therapeutic to treat tobacco use disorder complicating pregnancy and childbirth.

Moreover, in July 2022, AmerisourceBergen planned to launch digital therapeutics (DTx) platform to facilitate access to innovative products. The platform enables doctors to easily access and order prescription and non-prescription DTx through their e-prescribing workflow and monitor patient fulfilment of digital therapeutics and diagnostics.

Key features of the study:

This report provides in-depth analysis of the global digital therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.).

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital therapeutics market.

Detailed Segmentation:

Global Digital Therapeutics Market, By Application:

Diabetes

Obesity

Cardiovascular Disease (CVD)

Central Nervous System (CNS) Disease

Respiratory Disease

Smoking Cessation

Gastrointestinal Disorder (GID)

Others

Global Digital Therapeutics Market, By Product Type:

Software

Device

Global Digital Therapeutics Market, By Sales Channel:

Business-to-Business (B2B)

Employer

Healthcare Provider

Others

Business-to-Consumer (B2C)

Patient

Caregiver

Global Digital Therapeutics Market, By Geography:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Company Profiles:

Happify, Inc.

2Morrow, Inc.

Akili Interactive Labs, Inc.

Click Therapeutics, Inc.

Fitbit, Inc. (Twine Health, Inc.)

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Application; Market Snapshot, By Product Type; Market Snapshot, By Sales Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Rise in burden of chronic diseases around the world; Concerns about patient data privacy; Increasing adoption of digital therapeutics (DTx); Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Digital Therapeutics Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Digital Therapeutics Market, By Application, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018-2030; Segment Trends; Diabetes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Obesity; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Cardiovascular Disease (CVD); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Central Nervous System (CNS) Disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Respiratory Disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Smoking Cessation; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Gastrointestinal Disorder (GID); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Digital Therapeutics Market, By Product Type, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018-2030; Segment Trends; Software; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Device; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Global Digital Therapeutics Market, By Sales Channel, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018-2030; Segment Trends; Business-to-Business (B2B); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Employer; Healthcare Provider; Others; Business-to-Consumer (B2C); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Patient; Caregiver
8. Global Digital Therapeutics Market, By Region, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018-2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn); Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn); Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
9. Competitive Landscape: Happify, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; 2Morrow, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Akili Interactive Labs, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Click Therapeutics, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Fitbit, Inc. (Twine Health, Inc.); Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views; 10. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Digital Therapeutics Market” - forecast to 2030